VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Henagliflozein and Metformin
Phase 3
Small molecule
Z
Zhujiang Hospital
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
NAFLD
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
NAFLD
Phase 3
Recruiting
Clinical
Trials by Indication
[1]
NAFLD
1 trial
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Recruiting
·
Z
Zhujiang Hospital
·
Phase 4
·
NCT06449833
·
100 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Henagliflozein and Metformin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Henagliflozein and Metformin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Henagliflozein and Metformin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Zhujiang Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
Z
Zhujiang Hospital
Related News